A German company that provides products and services that accelerate drug development and manufacturing is set to acquire the ...

Germany’s Merck KGaA will buy Bio-Techne Corp. in a deal worth $11.3 billion, one of the largest acquisitions in Minnesota ...

The deal is Merck’s largest since 2015, when it spent $17bn on acquiring Sigma-Aldrich, also a life sciences specialist.

German pharma giant Merck has inked a deal to acquire US life sciences company Bio-Techne for $11. 3 billion to expand its ...

Merck KGaA agreed to buy Bio-Techne Corporation for about $11.3 billion to bolster its life-science business, marking the ...

Shares of U.S. life sciences company Bio-Techne jumped more than +22% in premarket trading on Thursday after Merck KGaA agreed to acquire the company for $73 per share in cash, va ...

Q1 beat and Bio-Techne deal drive upside, but valuation looks full. Read here for a detailed investment analysis.

Merck KGaA, Darmstadt, Germany, has agreed to acquire Bio-Techne for approximately $11.3 billion, the companies said today, in a deal designed to position the buyer as more of a leader across the life ...

Detailed price information for Bio-Techne Corp (TECH-Q) from The Globe and Mail including charting and trades.

Merck KGaA (ETR:MRK,OTCPL:MKGAF) has agreed to acquire life sciences supplier Bio-Techne (NASDAQ:TECH) for US$11.3 billion in ...

Germany's Merck KGaA is poised to increase the size of its life sciences business, which provides tools for research, drug discovery, and manufacturing, with an $11.3 billion deal to acquire US rival ...